Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain

Statistics

Original article

Análisis coste-efectividad de apixabán frente a acenocumarol en la prevención del ictus en pacientes con fibrilación auricular no valvular en España

Gonzalo Barón Esquiviasa, Ginés Escolar Albaladejob, José Luis Zamoranoc, Lourdes Betegón Nicolásd, Cristina Canal Fontcubertad, Marina de Salas-Cansadoe, Darío Rubio-Rodríguezf, Carlos Rubio-Terrésf,

Corresponding author

crubioterres@healthvalue.org

Corresponding author: Health Value, Virgen de Aránzazu 21, 5.o–B, 28034 Madrid, Spain.

a Servicio de Cardiología, Hospital Universitario Virgen del Rocío, Sevilla, Spain

b Servicio de Hemoterapia y Hemostasia, Hospital Clínic, Barcelona, Spain

c Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain

d Departamento de Economía de la Salud, Bristol-Myers Squibb España, Madrid, Spain

e Departamento de Farmacoeconomía y Resultados en Salud, Pfizer España, Madrid, Spain

f Health Value, Madrid, Spain

Read

16558

Times
was read the article

2775

Total PDF

13783

Total HTML

Share statistics

Article information

ISSN: 18855857
Original language: English

DOI:10.1016/j.rec.2014.08.010

The statistics are updated each day

Year/Month	Html	Pdf	Total

2023 December	4	2	6
2023 November	124	28	152
2023 October	146	28	174
2023 September	85	27	112
2023 August	86	16	102
2023 July	101	42	143
2023 June	106	14	120
2023 May	119	30	149
2023 April	82	27	109
2023 March	101	34	135
2023 February	90	43	133
2023 January	77	31	108
2022 December	72	26	98
2022 November	209	51	260
2022 October	200	135	335
2022 September	73	41	114
2022 August	118	44	162
2022 July	45	34	79
2022 June	172	27	199
2022 May	83	33	116
2022 April	148	33	181
2022 March	151	44	195
2022 February	147	27	174
2022 January	174	29	203
2021 December	216	33	249
2021 November	191	31	222
2021 October	236	43	279
2021 September	195	25	220
2021 August	155	29	184
2021 July	134	20	154
2021 June	142	24	166
2021 May	170	23	193
2021 April	275	74	349
2021 March	221	27	248
2021 February	115	23	138
2021 January	137	25	162
2020 December	140	39	179
2020 November	101	24	125
2020 October	121	24	145
2020 September	124	10	134
2020 August	117	19	136
2020 July	121	23	144
2020 June	124	41	165
2020 May	208	26	234
2020 April	173	16	189
2020 March	152	57	209
2020 February	146	18	164
2020 January	131	27	158
2019 December	186	27	213
2019 November	122	20	142
2019 October	111	30	141
2019 September	145	27	172
2019 August	117	42	159
2019 July	187	99	286
2019 June	149	88	237
2019 May	115	58	173
2019 April	155	18	173
2019 March	307	30	337
2019 February	337	21	358
2019 January	385	26	411
2018 December	426	27	453
2018 November	373	25	398
2018 October	444	18	462
2018 September	183	14	197
2018 August	86	18	104
2018 July	107	14	121
2018 June	164	20	184
2018 May	182	23	205
2018 April	332	7	339
2018 March	73	9	82
2018 February	56	16	72
2018 January	56	8	64
2017 December	56	13	69
2017 November	72	18	90
2017 October	70	14	84
2017 September	60	14	74
2017 August	78	19	97
2017 July	64	21	85
2017 June	83	29	112
2017 May	92	31	123
2017 April	62	7	69
2017 March	71	14	85
2017 February	159	17	176
2017 January	71	21	92
2016 December	97	22	119
2016 November	105	23	128
2016 October	169	17	186
2016 September	224	33	257
2016 August	135	17	152
2016 July	121	16	137
2016 June	102	45	147
2016 May	120	35	155
2016 April	163	27	190
2016 March	98	23	121
2016 February	145	51	196
2016 January	7	8	15
2015 December	0	2	2
2015 November	0	1	1
2015 October	0	2	2
2015 September	0	2	2
2015 August	1	1	2
2015 July	2	0	2

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter

Subscribe to our newsletter